🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

RecruitingPhase 3Ages 18 Years - anyAllSherief Abd-Elsalam
NCT03647072 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * DLBCL Lymphoma subtype --No comorbid disease Exclusion Criteria: * Pregnancy * Peptic ulcer * Severe cardiac disease * Osteoporosis
💊

What it tests

  • CHOP
  • CHOP Plus Lanzoprazole
  • CHOP Plus Famotidine
📍

Where

1 site
Sherief Abd-Elsalam
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy